HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Secret Skin Renewal TV, Print Ads Promote Skin Conditioning Benefits

This article was originally published in The Rose Sheet

Executive Summary

Procter & Gamble is supporting the March launch of Secret Skin Renewal Antiperspirant/Deodorant with print ads highlighting the product's skin conditioning benefits

You may also be interested in...



AAD In Brief

Revlon lipstick research: Regular use of a lipstick can have a beneficial effect on cheilosis, Stanley Levy et al., Revlon Research Center, conclude in a poster study presented at American Academy of Dermatology Annual Meeting in San Francisco March 21-26. Researchers evaluated twice daily application of cosmetic lip product for four weeks on 28 female lipstick users ages 19-57. "Statistically significant improvements" in fine lines, scaling and fissuring and overall lip appearance seen at four weeks, researchers note. However, coarse lines were not improved, Levy et al. add. Revlon also presented research on Almay Lip Vitality and its ability to improve signs of cheilosis. Lip Vitality Smoothing Lipcolor with Kinetin debuted in July (1"The Rose Sheet" April 29, 2002, Marketing In Brief)...

OCA Applauds Organic Board's Recommendation To USDA: "Outlaw Nanotech"

With a push from the Organic Consumers Association, the National Organic Standards Board is recommending that the use of nanotechnology be strictly prohibited from products certified under the National Organic Program

Latest Headlines
See All
UsernamePublicRestriction

Register

RS010999

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel